Phio Pharmaceuticals Corp.
Nasdaq · Healthcare · Pharmaceutical Preparations · King Of Prussia, PA
PHIO chart
What traders are saying about $PHIO
Latest postsPhio Pharmaceuticals Corp. news
- Phio Pharmaceuticals Announces e-Presentation at American Society for Dermatologic Surgery (ASDS) Annual Meeting
Yahoo Finance ·
- Phio Pharmaceuticals Reports Q3 2026 Results and Business Update as It Advances PH-762 Toward Phase 2b Study
The Detroit News ·
- Phio Pharmaceuticals Reports Third Quarter 2026 Financial Results and Business Update as It Advances PH-762 Toward Phase 2b Study Initiation
investorshub.advfn.com ·
- Phio Pharmaceuticals to present Phase 1b trial data at SITC By Investing.com
Investing.com Australia ·
- Phio Pharmaceuticals to present Phase 1b skin cancer data at SITC
StreetInsider ·
- Phio Pharmaceuticals Announces Invitation for Oral Presentation at 41st Annual SITC Meeting (Society for Immunotherapy of Cancer)
Yahoo Finance ·
- Study results suggest a skin cancer treatment may spare tissue before surgery
Stock Titan ·
- Phio Pharmaceuticals Corp. (PHIO) Misses Q3 EPS by 1c
StreetInsider ·
- With $10.6M in cash, Phio Pharmaceuticals (PHIO) warns it may not cover planned operations.
Stock Titan ·
- Phio Pharmaceuticals Reports $4.2 Million Q3 Net Loss and PH-762 Progress
TradingView ·
- A potential non-surgical skin cancer treatment is expected to enter a new study in early 2027.
Stock Titan ·
- Phio Pharmaceuticals Corp. (PHIO) Seasonal returns chart
Yahoo Finance UK ·
Phio Pharmaceuticals Corp. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | – | – | – | – |
| Net income | -$8.7M | -$7.2M | -$10.8M | -$11.5M |
| Diluted EPS | – | $-9.08 | $-46.76 | $-10.10 |
| Total assets (year end) | $21.5M | $5.7M | $9.4M | $12.8M |
| Cash and equivalents (year end) | $21.0M | $5.4M | $8.5M | – |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Phio Pharmaceuticals Corp.
- Ticker
- PHIO (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- King Of Prussia, PA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1533040
- Former names
- RXi Pharmaceuticals Corp
Frequently asked questions
What exchange is Phio Pharmaceuticals Corp. listed on?
Phio Pharmaceuticals Corp. trades on the Nasdaq under the ticker symbol PHIO.
What industry is Phio Pharmaceuticals Corp. in?
Phio Pharmaceuticals Corp. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Phio Pharmaceuticals Corp. headquartered?
Phio Pharmaceuticals Corp.'s business address on file with the SEC is in King Of Prussia, PA.
When does Phio Pharmaceuticals Corp.'s fiscal year end?
Phio Pharmaceuticals Corp.'s fiscal year ends on December 31.
How much revenue did Phio Pharmaceuticals Corp. report?
Phio Pharmaceuticals Corp. reported $0 in revenue for calendar year 2020, according to its SEC filings.